当前位置: 首页 > 期刊 > 《医学信息》 > 2025年第14期
编号:2386651
盐酸西替利嗪联合孟鲁司特钠治疗小儿喘息性支气管炎的效果及对炎性指标的影响
http://www.100md.com 2025年8月13日 医学信息 2025年第14期
     中图分类号:R562.2文献标识码:A

    DOI:10.3969/j.issn.1006-1959.2025.14.017 文章编号:1006-1959(2025)14-0095-04

    Abstract:OjetieTseetftoftiehdoodombdwioteukastiinreatmntofsthaticoiin childrennditsifencomatordees.MetdsUsingedomumberableetod64cdenitstaticocis diagnosedandtreatedinourhospitalfromJauary1toJuly24weredividedintocontrolgoupndservatiogroup32cirenoup. Thecontrolgroastreaedioeuast,ndthseatiogroastreatediierolodeotsisfol group.Thellodelotalliefald incidenceofdeactioseompaedttoosesultsotaltieateofentibseoou(968 % ) was higher than that in the control group (81.25 % )(Plt;0.05).The WBC,CRP and eosinophil count of the two groups after treatment were lower than thosebefortreatdpeditrolouesoltfeaioeeatlor 0 P lt;0.05).Theremsiotiofshorsofeathheingoughdpulmoarystainthbseatiogrouasshoterthantatinte control group( Plt;0.05) .The scoresof cough,asthma and asthma sound inthe observation group were lowerthanthose in thecontrol group (Plt;0.05) There was no significant difference in the incidence of adverse reactions between the observation group (6.25 % )and the control group (9.38 % ) Pgt; (204号 0.05).CnclusCetrerclodeobdwioteukastsdasodtinetreamntofsaticciisre whichcanipietatoueodl incidence of adverse reactions. ......

您现在查看是摘要页,全文长 10579 字符